Seguir
Gwyn Bebb
Gwyn Bebb
Professor, University of Calgary
Dirección de correo verificada de ahs.ca
Título
Citado por
Citado por
Año
ATM deficiency sensitizes mantle cell lymphoma cells to poly (ADP-ribose) polymerase-1 inhibitors
CT Williamson, H Muzik, AG Turhan, A Zamò, MJ O'Connor, DG Bebb, ...
Molecular cancer therapeutics 9 (2), 347-357, 2010
2102010
Evaluation of immunohistochemical markers in non‐small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers
NHC Au, M Cheang, DG Huntsman, E Yorida, A Coldman, WM Elliott, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2004
1732004
Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes
RJ de Leeuw, JJ Davies, A Rosenwald, G Bebb, RD Gascoyne, MJS Dyer, ...
Human molecular genetics 13 (17), 1827-1837, 2004
1502004
Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53
CT Williamson, E Kubota, JD Hamill, A Klimowicz, R Ye, H Muzik, M Dean, ...
EMBO molecular medicine 4 (6), 515-527, 2012
1472012
Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines
E Kubota, CT Williamson, R Ye, A Elegbede, L Peterson, SP Lees-Miller, ...
Cell cycle 13 (13), 2129-2137, 2014
1452014
Current landscape of immunotherapy in the treatment of solid tumours, with future opportunities and challenges
NA Nixon, N Blais, S Ernst, C Kollmannsberger, G Bebb, M Butler, ...
Current oncology 25 (5), 373-384, 2018
1402018
Nimotuzumab: a novel anti-EGFR monoclonal antibody that retains anti-EGFR activity while minimizing skin toxicity
WK Boland, G Bebb
Expert opinion on biological therapy 9 (9), 1199-1206, 2009
1312009
ATM-deficient colorectal cancer cells are sensitive to the PARP inhibitor olaparib
C Wang, N Jette, D Moussienko, DG Bebb, SP Lees-Miller
Translational oncology 10 (2), 190-196, 2017
1142017
The CXCR4/SDF-1 chemokine receptor axis: a new target therapeutic for non-small cell lung cancer
S Otsuka, G Bebb
Journal of Thoracic Oncology 3 (12), 1379-1383, 2008
942008
Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV …
G Bebb, C Smith, S Rorke, W Boland, L Nicacio, R Sukhoo, A Brade
Cancer chemotherapy and pharmacology 67, 837-845, 2011
912011
CXCR4 overexpression is associated with poor outcome in females diagnosed with stage IV non-small cell lung cancer
S Otsuka, AC Klimowicz, K Kopciuk, SK Petrillo, M Konno, D Hao, H Muzik, ...
Journal of Thoracic Oncology 6 (7), 1169-1178, 2011
782011
The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status
M Kim, CT Williamson, J Prudhomme, DG Bebb, K Riabowol, PWK Lee, ...
Oncogene 29 (27), 3990-3996, 2010
762010
Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment
D Hao, MO Sarfaraz, F Farshidfar, DG Bebb, CY Lee, CM Card, M David, ...
Metabolomics 12, 1-9, 2016
752016
Physical activity and diet behaviour in colorectal cancer patients receiving chemotherapy: associations with quality of life
LE Stephenson, DG Bebb, RA Reimer, SN Culos-Reed
BMC gastroenterology 9, 1-9, 2009
742009
The lung immune prognostic index discriminates survival outcomes in patients with solid tumors treated with immune checkpoint inhibitors
DE Meyers, I Stukalin, IA Vallerand, RT Lewinson, A Suo, M Dean, ...
Cancers 11 (11), 1713, 2019
602019
Correlations of EGFR mutations and increases in EGFR and HER2 copy number to gefitinib response in a retrospective analysis of lung cancer patients
TJ Pugh, G Bebb, L Barclay, M Sutcliffe, J Fee, C Salski, R O'Connor, ...
BMC cancer 7, 1-12, 2007
572007
Bias and variability in blood pressure measurement with ambulatory recorders.
G Pannarale, G Bebb, S Clark, A Sullivan, C Foster, AJ Coats
Hypertension 22 (4), 591-598, 1993
571993
Asian ethnicity and adenocarcinoma histology continues to predict response to gefitinib in patients treated for advanced non-small cell carcinoma of the lung in North America
C Ho, N Murray, J Laskin, B Melosky, H Anderson, G Bebb
Lung Cancer 49 (2), 225-231, 2005
552005
Shame, guilt, and communication in lung cancer patients and their partners
D Dirkse, L Lamont, Y Li, A Simonič, G Bebb, J Giese–Davis
Current Oncology 21 (5), 718-722, 2014
542014
Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancer
DG Bebb, Z Yu, J Chen, M Telatar, K Gelmon, N Phillips, RA Gatti, ...
British journal of cancer 80 (12), 1979-1981, 1999
521999
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20